Welcome to Sunday. The top 5 most-read stories of the week are displayed below. Below that are five editors’ selections that we want to make sure you don’t miss.

You can also get the most-read stories in a magazine-style e-book.

Everyone needs a safe place to live. But American popular culture often dismisses one affordable option – trailer parks. In one of our most-read stories this week, a group of planning professors suggests that letting go of stereotypes about “trashy” trailer parks could help address the nation’s housing crunch. If you think of mobile homes as particularly flimsy, crime-ridden or vulnerable to natural disasters, this article aims to change the way you think.

In editors’ picks, don’t miss a new Q+A with virologist Maureen Ferran of Rochester Institute of Technology. Ferran – who has helped us understand COVID-19 over the past couple of years – now answers our questions about two vaccines available to protect against monkeypox. There have been more than 7,000 confirmed cases of monkeypox in the U.S. to date, and the government declared it a national health emergency on Thursday.

Next week, we’ll bring you stories about why President Biden doesn’t want to be a lame duck, what happens when police are required to go to college and how to keep kids safe in the water.

Emily Costello

Managing Editor

Readers' picks

Certain SSRIs can inhibit the breakdown of opioids in the body. Glasshouse Images/The Image Bank via Getty Images

Taking certain opioids while on commonly prescribed antidepressants may increase the risk of overdose

Ismaeel Yunusa, University of South Carolina

Drugs can interact with one another in ways that are harmful. A study finds that taking oxycodone with certain SSRIs can make an opioid overdose more likely.

Editors' picks

The Jynneos monkeypox vaccine provides strong protection against infection but is in short supply. Mario Tama/Getty Images

Monkeypox vaccines: A virologist answers 6 questions about how they work, who can get them and how well they prevent infection

Maureen Ferran, Rochester Institute of Technology

There are two approved monkeypox vaccines in the US. Both use a related poxvirus called vaccinia to produce an immune response that protects against smallpox and monkeypox.

Like this newsletter? You might be interested in our other weekly emails:

About The Conversation:

We're a nonprofit news organization dedicated to helping academic experts share ideas with the public. We can give away our articles thanks to the help of foundations, universities and readers like you.

Donate now to support research-based journalism